Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

v3.22.0.1
Subsequent Events
6 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events

Note 9. Subsequent Events

 

On December 31, 2021, Daniel Schneeberger, M.D. advised the Company of his resignation as Chief Executive Officer “CEO” of the Company and from the Board of Directors, effective on February 1, 2022. On January 3, 2022, Simon Allen was appointed to be the Company’s CEO and elected a member of the Board of Directors, both of which became effective on February 1, 2022. Pursuant to his employment agreement, Mr. Allen will receive a base salary during the term of his employment at an annual rate of $450,000. The Company also agreed to issue stock options to Mr. Allen under our 2020 Stock Incentive Plan to purchase a total of 625,000 shares.